Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?

Area of Science:

• Microbiology and Infectious Diseases
• Virology
• Therapeutic Strategies

Background:

• Bacterial infections pose a significant global health threat, with antibiotic resistance limiting treatment efficacy.
• The rise of antibiotic-resistant microbes necessitates novel therapeutic approaches to reduce disease burden and economic impact.
• Antibiotic overuse has accelerated the evolution of resistant bacterial strains, highlighting the urgent need for alternatives.

Approach:

• This review synthesizes current knowledge on bacteriophage therapy, examining its potential as an alternative to conventional antibiotics.
• It analyzes the advantages and disadvantages of using bacteriophages to treat microbial infections.
• The review discusses the current status of clinical trials and the historical, present, and future outlook of phage therapy.

Key Points:

• Bacteriophages, viruses that infect bacteria, are a promising tool to combat antibiotic resistance.
• Phage therapy has demonstrated successful patient outcomes in experimental settings and is under investigation in clinical trials.
• Understanding the host's immunological response to phage administration is crucial for optimizing therapy.

Conclusions:

• Bacteriophage therapy presents a viable alternative to antibiotics for treating bacterial infections, especially in the face of rising resistance.
• Further research into phage therapy, including host immune responses, is essential for its widespread clinical application.
• The field of phage therapy is rapidly advancing, offering hope for a future less dependent on traditional antimicrobial agents.